{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:16Z","timestamp":1761896476845,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.bbmt.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T15:08:19Z","timestamp":1483628899000},"page":"581-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma"],"prefix":"10.1016","volume":"23","author":[{"given":"Ankur","family":"Varma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Biritxinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima M.","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Stich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Francesca","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimaz","family":"Afrough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhavi","family":"Honhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uday R.","family":"Popat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehnaz A.","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qaiser","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Hosing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffar H.","family":"Qazilbash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.01.005_bib0010","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"author":"Centers for Disease Control and Prevention","key":"10.1016\/j.bbmt.2017.01.005_bib0015"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bmt.1700744","article-title":"Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study","volume":"19","author":"Lau","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0030","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.1999.17.1.394","article-title":"Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem","volume":"17","author":"Liang","year":"1999","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2017.01.005_bib0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/8.suppl_1.S107","article-title":"Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan","volume":"8","author":"Kumagai","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bmt.1702093","article-title":"Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period","volume":"25","author":"Iwai","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"RR\u201316","key":"10.1016\/j.bbmt.2017.01.005_bib0045","first-page":"1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II. Immunization of adults","volume":"55","author":"Mast","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0050","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ajg.2009.669","article-title":"Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age","volume":"105","author":"Tai","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0055","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2003.50171","article-title":"Long-term histologic and virologic outcomes of acute self-limited hepatitis B","volume":"37","author":"Yuki","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0060","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0065","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1053\/jhep.2003.50220","article-title":"Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma","volume":"37","author":"Cheng","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0070","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1200\/JCO.2014.56.7081","article-title":"Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study","volume":"32","author":"Seto","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2008.18.0182","article-title":"Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab","volume":"27","author":"Yeo","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00007890-199809150-00012","article-title":"Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc","volume":"66","author":"Dhedin","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1703614","article-title":"Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease","volume":"30","author":"Seth","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/01.TP.0000151661.52601.FB","article-title":"Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection","volume":"79","author":"Onozawa","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2893.2006.00830.x","article-title":"Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor","volume":"14","author":"Knoll","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbmt.2009.12.532","article-title":"Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Ramos","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/annonc\/mdr142","article-title":"Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection","volume":"23","author":"Mya","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0110","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1590\/S1807-59322011001200010","article-title":"Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes","volume":"66","author":"Teng","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/10428194.2011.610013","article-title":"High prevalence of hepatitis B virus infection in multiple myeloma","volume":"53","author":"Huang","year":"2012","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0120","doi-asserted-by":"crossref","first-page":"O694","DOI":"10.1111\/1469-0691.12611","article-title":"Hepatitis B reactivation in HBsAg-negative\/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome","volume":"20","author":"Mikulska","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0125","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0130","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2008-1040593","article-title":"Fulminant and subfulminant liver failure: definitions and causes","volume":"6","author":"Bernuau","year":"1986","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1703818","article-title":"Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients","volume":"31","author":"Terpos","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0150","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJMoa022340","article-title":"High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma","volume":"348","author":"Child","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0155","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1200\/JCO.2012.48.5938","article-title":"Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B","volume":"31","author":"Huang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5045\/br.2015.50.1.51","article-title":"HBV reactivation in a HBsAg-negative patient with multiple myeloma treated with prednisolone maintenance therapy after autologous HSCT","volume":"50","author":"Gu","year":"2015","journal-title":"Blood Res"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3960\/jslrt.52.67","article-title":"Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy: case report","volume":"52","author":"Tanaka","year":"2012","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1665-2681(19)30855-5","article-title":"Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance","volume":"13","author":"Yang","year":"2014","journal-title":"Ann Hepatol"},{"author":"FDA Drug Safety Communication.","key":"10.1016\/j.bbmt.2017.01.005_bib0175"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0180","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3109\/10428194.2014.941833","article-title":"Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant","volume":"56","author":"Li","year":"2015","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0185","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0190","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbmt.2009.05.001","article-title":"Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Hammond","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.01.005_bib0195","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1002\/cncr.25253","article-title":"Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma","volume":"116","author":"Matsue","year":"2010","journal-title":"Cancer"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117300757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117300757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:59:02Z","timestamp":1761058742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117300757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1083879117300757"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.01.005","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}